TTKHLTCARE Share Price Target 2035

CAGR-based price projection for TTK Healthcare Limited (TTKHLTCARE) targeting 2035, derived from official NSE exchange closing prices.

Bear Case (5.7% CAGR)
Rs 1,671
2035 Target
Base Case (14.3% CAGR)
Rs 3,370
2035 Target
Bull Case (39.8% CAGR)
Rs 20,669
2035 Target

Current Market Snapshot

CMP: Rs 1,013.00
52W High: Rs 1,191.00
52W Low: Rs 855.55
1Y CAGR: 30.6%
3Y CAGR: 14.3%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 1,071 Rs 1,158 Rs 1,416
2028 Rs 1,132 Rs 1,323 Rs 1,980
2029 Rs 1,197 Rs 1,512 Rs 2,768
2030 Rs 1,265 Rs 1,728 Rs 3,870
2031 Rs 1,338 Rs 1,975 Rs 5,410
2032 Rs 1,414 Rs 2,258 Rs 7,564
2033 Rs 1,495 Rs 2,580 Rs 10,575
2034 Rs 1,580 Rs 2,949 Rs 14,784
2035 Rs 1,671 Rs 3,370 Rs 20,669

Other TTKHLTCARE Price Targets

2025 2026 2027 2028 2030 2040 2050

Frequently Asked Questions

What is the TTKHLTCARE share price target for 2035?

Based on historical growth analysis, the TTKHLTCARE share price target for 2035 ranges from Rs 1,671 (conservative) to Rs 3,370 (base case) to Rs 20,669 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of TTKHLTCARE?

The current market price of TTKHLTCARE (TTK Healthcare Limited) is Rs 1,013.00. The 52-week high is Rs 1,191.00 and 52-week low is Rs 855.55.

Is TTKHLTCARE a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for TTKHLTCARE price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 5.7% CAGR), Base (14.3% CAGR), and Bull (optimistic at 39.8% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.